A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease - PubMed

Mon, Nov 17

Perspectives

Interesting! 'We initially demonstrate that low-dose THC-CBD potentially can be an effective and safe therapeutic option for AD-related dementia.' #CannabisCommunity https://t.co/WLHKekJPyl

8441

BackgroundPreclinical and clinical evidence suggest that low-dose cannabinoids could ameliorate Alzheimer's disease (AD) signs and symptoms. We designed this trial to evaluate the safety and efficacy...

Discover